Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis
H De Lavallade, JF Apperley, JS Khorashad… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Imatinib is remarkably effective in treating newly diagnosed patients with chronic
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
Imatinib for newly diagnosed patients with chronic myeloid leukemia: Incidence of sustained responses in an intention-to-treat analysis
H de Lavallade, JF Apperley… - Journal of …, 2008 - mdanderson.elsevierpure.com
Purpose: Imatinib is remarkably effective in treating newly diagnosed patients with chronic
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis
H de Lavallade, JF Apperley… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose Imatinib is remarkably effective in treating newly diagnosed patients with chronic
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis.
H de Lavallade, JF Apperley, JS Khorashad… - Journal of Clinical …, 2008 - europepmc.org
Purpose Imatinib is remarkably effective in treating newly diagnosed patients with chronic
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
H De Lavallade, JF Apperley, JS Khorashad - leukemia-cell.org
Úvod: Imatinib je pozoruhodně efektivní v léčbě pacientů s nově diagnostikovanou
chronickou myeloidní leukémií (CML) v chronické fázi (CP). Většina dostupných údajů o …
chronickou myeloidní leukémií (CML) v chronické fázi (CP). Většina dostupných údajů o …
[PDF][PDF] Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
H de Lavallade, JF Apperley, JS Khorashad… - J Clin Oncol, 2008 - academia.edu
Purpose Imatinib is remarkably effective in treating newly diagnosed patients with chronic
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
H de Lavallade, JF Apperley, JS Khorashad… - Journal of Clinical …, 2008 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Imatinib is remarkably effective in
treating newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase …
treating newly diagnosed patients with chronic myeloid leukemia (CML) in chronic phase …
[引用][C] Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
H DE LAVALLADE, JF APPERLEY… - Journal of clinical …, 2008 - pascal-francis.inist.fr
Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia : Incidence of
Sustained Responses in an Intention-to-Treat Analysis CNRS Inist Pascal-Francis CNRS …
Sustained Responses in an Intention-to-Treat Analysis CNRS Inist Pascal-Francis CNRS …
[引用][C] Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis
DE LAVALLADE - J Clin Oncol, 2008 - cir.nii.ac.jp
Imatinib for newly diagnosed patients with chronic myeloid leukemia : incidence of sustained
responses in an intention-to-treat analysis | CiNii Research CiNii 国立情報学研究所 学術情報 …
responses in an intention-to-treat analysis | CiNii Research CiNii 国立情報学研究所 学術情報 …
[PDF][PDF] Imatinib for Newly Diagnosed Patients With Chronic Myeloid Leukemia: Incidence of Sustained Responses in an Intention-to-Treat Analysis
H de Lavallade, JF Apperley, JS Khorashad… - J Clin Oncol, 2008 - academia.edu
Purpose Imatinib is remarkably effective in treating newly diagnosed patients with chronic
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …
myeloid leukemia (CML) in chronic phase (CP). To date, most of the available data come …